TY  - JOUR
AU  - Chatwal, Monica S.
AU  - Tanvetyanon, Tawee
PY  - 2018
TI  - Combination chemotherapy and immunotherapy in metastatic non-small cell lung cancer: a setback for personalized medicine?
JF  - Translational Lung Cancer Research; Vol 7, Supplement 3 (September 26, 2018): Translational Lung Cancer Research1
Y2  - 2018
KW  - 
N2  - The management landscape for metastatic non-small cell lung cancer (NSCLC) has changed considerably beyond chemotherapy alone. This is due to the introduction of targeted therapies for patients with targetable mutations and the advent of immune checkpoint inhibitors.
UR  - https://tlcr.amegroups.org/article/view/23127